Zobrazeno 1 - 10
of 48
pro vyhledávání: '"RW Lord"'
Autor:
Kartik Kumar, Thomas Scoones, RW Lord, Andrew M. Jones, Michael R. Loebinger, Laura Macfarlane
Publikováno v:
Clin Med (Lond)
Bronchiectasis is a heterogeneous and increasingly prevalent chronic pulmonary disease that is associated with significant morbidity. In this review, we outline how patients with bronchiectasis may present clinically and describe an approach to its d
Autor:
Valentyn Moskalenko, Nathan D. Pfeifer, Brett Haumann, Edmund J. Moran, Elad Kaufman, Glenn Crater, David A. Lombardi, David L. Bourdet, RW Lord, Ashley Woodcock, Jacky Woo, Dave Singh, Maxim Bogus, Tuan Nguyen, Rajeev Saggar, Emily Y. Weng
BackgroundLung-targeted anti-inflammatory therapy could potentially improve outcomes in patients with COVID-19. The novel inhaled pan-Janus kinase (JAK) inhibitor TD-0903 was designed to optimise delivery to the lungs while limiting systemic exposure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::40423d33da822e5548c57baa4f6ff857
https://doi.org/10.1101/2021.03.09.21252944
https://doi.org/10.1101/2021.03.09.21252944
Autor:
RW Lord, Andrew M. Jones, Peter J. Barry, Dipesh H. Vasant, Peter J. Whorwell, Jane Wych, A.L. Brennan, Sharon Archbold, Jacky Smith
Publikováno v:
Posters.
Autor:
RW Lord, Elad Kaufman, Nathan D. Pfeifer, Glenn Crater, Edmund J. Moran, Ashley Woodcock, Rajeev Saggar, Jacky Woo, Maxim Bogus, Dave Singh, David L. Bourdet, Tuan Nguyen, Emily Y. Weng, Valentyn Moskalenko, Brett Haumann, David A. Lombardi
Publikováno v:
Singh, D, Bogus, M, Moskalenko, V, Lord, R, Moran, E J, Crater, G D, Bourdet, D L, Pfeifer, N D, Woo, J, Kaufman, E, Lombardi, D A, Weng, E Y, Nguyen, T, Woodcock, A, Haumann, B & Saggar, R 2021, ' A phase 2 multiple ascending dose study of the inhaled pan-JAK inhibitor nezulcitinib (TD-0903) in severe COVID-19 ', European Respiratory Journal, vol. 58, no. 4, 2100673 . https://doi.org/10.1183/13993003.00673-2021
The inhaled lung-selective pan-JAK inhibitor nezulcitinib appears generally well tolerated in hospitalised patients with severe #COVID-19, with trends for improved oxygenation and clinical status, shortened hospitalisation, and fewer deaths versus pl
Autor:
Joseph Elborn, RW Lord, Andrew M. Jones, A.J. Lee, Gisli G. Einarsson, Michael M. Tunney, B. Bianco, Peter J. Whorwell
Publikováno v:
Cystic fibrosis and bronchiectasis: updates and controversies.
Background It has been proposed that the increased amounts of gastro-oesophageal reflux seen in cystic fibrosis (CF) patients can lead to reflux aspiration, which in turn may influence the lung microbiome. The aim of this study was to assess microbia
Autor:
Gisli G. Einarsson, RW Lord, Andrew M. Jones, Joseph Elborn, A.J. Lee, Michael M. Tunney, Jacky Smith
Publikováno v:
Cystic fibrosis and bronchiectasis: updates and controversies.
Background Historically during microbiological observations sputum has been thought to represent the ‘lower’ airway or the lung environment. However, during expectoration sputum passes through the oropharynx, potentially resulting in contaminatio
Autor:
Robert J. Beynon, Victoria M. Harman, Paul S. McNamara, R.E. Maher, RW Lord, B. Bianco, Andrew M. Jones, Peter J. Whorwell, Jacky Smith
Publikováno v:
Biomarkers and treatments in cystic fibrosis.
Introduction There is potential for protein biomarkers to assist with clinical decision making in cystic fibrosis (CF) patients, such as when to commence and cease antibiotic therapy. Several small proteomic studies in CF populations have identified
Autor:
Victoria M. Harman, B. Bianco, Paul S. McNamara, Rosemary Maher, Robert J. Beynon, Jacky Smith, RW Lord, Andrew M. Jones
Publikováno v:
Cystic fibrosis.
Autor:
A.J. Lee, Michael M. Tunney, Gisli G. Einarsson, Stuart Elborn, RW Lord, Andrew M. Jones, Jackie Smith
Publikováno v:
Journal of Cystic Fibrosis. 19:S78
Autor:
Michael M. Tunney, Gisli G. Einarsson, Stuart Elborn, RW Lord, A.J. Lee, Andrew M. Jones, Jackie Smith
Publikováno v:
Journal of Cystic Fibrosis. 19:S79